Mitochondrial translocation of amyloid precursor protein and its cleaved products: Relevance to mitochondrial dysfunction in Alzheimer's disease

Reviews in the Neurosciences

Volumn 18, Issue 5, 2007, Pages 343-354

  Anandatheerthavarada, Hindupur K ^a   Devi, Latha ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Acidic domain; Alzheimer's disease; Amyloid precursor protein; A ; Human postmortem brains; Import channels; Mitochondria; Neurons; Transgenic mouse models; Translocational arrest

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; PROTEINASE;

ALZHEIMER DISEASE; BRAIN; CELL FUNCTION; CELLULAR DISTRIBUTION; CYTOLOGY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; MITOCHONDRION; MODEL; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; REVIEW; CARBOXY TERMINAL SEQUENCE; MITOCHONDRIAL TARGETING SIGNAL; PATHOGENESIS; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION;

EID: 37349022384     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/revneuro.2007.18.5.343     Document Type: Review

References (73)

1. 2-terminal-processed microsomal protein to mitochondria: a novel pathway for the biogenesis of hepatic mitochondrial P450MT2. J Cell Biol 1997; 139: 589-599.
2. Anandatheerthavarada HK, Biswas G, Mullick J, Sepuri NB, Otvos L, Pain D, Avadhani NG. Dual targeting of cytochrome P4502B1 to endoplasmic reticulum and mitochondria involves novel signal activation by cyclic AMP-dependent phosphorylation at Ser128. EMBO J 1999; 18: 5494-5504.
3. Anandatheerthavarada HK, Biswas G, Robin MA, Avadhani NG. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol 2003; 161: 41-54.
4. Annaert WG, Levesque L, Craessaerts K, Dierinck I, Snellings G, Westaway D, George-Hyslop PS, Cordell B, Fraser P, De Strooper B. Presenilin 1 controls γ-secretase processing of amyloid precursor protein in pre-Golgi compartments of hippocampal neurons. J Cell Biol 1999; 147: 277-294.
5. Askanas V, McFerrin J, Baque S, Alvarez RB, Sarkozi E, Engel WK, Transfer of β-amyloid precursor protein gene using Adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle. Proc Natl Acad Sci USA 1996; 93: 1314-1319.
6. Bahmanyar S, Higgins GA, Goldgaber D, Lewis DA, Morrison JH, Wilson MC, Shankar SK, Gajdusek DC. Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer's disease. Science 1987; 237: 77-80.
7. Basun H, Forssell LG, Wetterberg L, Winblad B. Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease. J Neural Transm Park Dis Dement Sect 1991; 3: 231-258.
8. Beal MF. Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1998; 1366: 211-223.
9. Beal MF. Mitochondria take center stage in aging and neurodegeneration. Ann Neurol 2005; 58: 495-505.
10. Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, Prada CM, Kim G, Seekins S, Yager D, Slunt HH, Wang R, Seeger M, Levey AI, Gandy SE, Copeland NG., Jenkins NA, Price DL, Younkin SG, Sisodia SS. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron 1996; 17: 1005-1013.
11. Busciglio J, Pelsman A, Wong C, Pigino G, Yuan M, Mori H, Yankner BA. Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome. Neuron 2002; 33: 677-688.
12. Cardoso SM, Santos S, Swerdlow RH, Oliveira CR. Functional mitochondria are required for amyloid beta-mediated neurotoxicity. FASEB J 2001; 15: 1439-1441.
13. Casley CS, Canevari L, Land JM, Clark JB, Sharpe MA. Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J Neurochem 2002; 80: 89-100.
14. Caspersen C, Wang N, Yao J, Sosunov A, Chen X, Lustbader JW, Xu HW, Stern D, McKhann G, Yan SD. Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease FASEB J 2005; 19: 2040-2041.
15. Chandrasekaran K, Hatanpaa K, Brady DR, Stoll J, Rapoport SI. Downregulation of oxidative phosphorylation in Alzheimer disease: loss of cytochrome oxidase subunit mRNA in the hippocampus and entorhinal cortex. Brain Res 1998; 796: 13-19.
16. Chang S, Ma T, Miranda D, Balestra ME, Mahley RW, Huang Y. Lipid- and receptor-binding domains of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc Natl Acad Sci USA 2005; 102: 18694-18699.
17. Crouch PJ, Blake R, Duce JA, et al. Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-β1-42. J Neurosci 2005; 25: 672-679.
18. Cummings JL. Cognitive and behavioral heterogeneity in Alzheimer's disease: seeking the neurobiological basis. Neurobiol Aging 2000; 21: 845-861.
19. David DC, Hauptmann S, Scherping I, Schuessel K, Keil U, Rizzu P, Ravid R, Dröse S, Brandt U, Müller WE, Eckert E, Gotz J. Proteomic and functional analysis reveal a mitochondrial dysfunction in P301L tau transgenic mice. J Biol Chem 2005; 280: 23802-23814.
20. Devi L, Prabhu BM, Galati DF, Avadhani NG, Anandatheerthavarada HK. Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J Neurosci 2006; 30: 9057-9068.
21. Ellison DW, Beal MF, Mazurek MF, Bird ED, Martin JB. A postmortem study of amino acid neurotransmitters in Alzheimer's disease. Ann Neurol 1986; 20: 616-621.
22. Falkevall A, Alikhani N, Bhushan S, Pavlov PF, Busch K, Johnson KA, Eneqvist T, Tjernberg L, Ankarcrona M, Glaser E. Degradation of the amyloid beta protein by the novel mitochondrial peptidasome, PreP. J Biol Chem 2006; 281: 29096-29104,
23. Gabaldon T, Huynen MA. Shaping the mitochondrial proteome. Biochim Biophys Acta 2004; 1659: 212-220.
24. Gibson GE, Haroutunian V, Zhang H, Park LC, Shi Q, Lesser M, Mohs RC, Sheu RK, Blass JP. Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype. Ann Neurol 2000; 48: 297-303.
25. Gouras GK, Almeida CG, Takahashi RH. Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease. Neurobiol Aging 2005; 26: 1235-1244.
26. Grant SM, Shankar SL, Chalmers-Redman RM, Tatton WG, Szyf M, Cuello AC. Mitochondrial abnormalities in neuroectodermal cells stably expressing human amyloid precursor protein (hAPP751). NeuroReport 1999; 18: 41-46.
27. Hansson CA, Frykman S, Farmery MR, Tjernberg LO, Nilsberth C, Pursglove SE, Ito A, Winblad B, Cowburn RF, Thyberg J, Ankarcrona M. Nicastrin, presenilin, APH-1, and PEN-2 form active γ-secretase complexes in mitochondria. J Biol Chem 2004; 279: 51654-51660.
28. Hasimoto Y, Niikura T, Ito Y, Nishimoto I. Multiple mechanisms underlie neurotoxicity by different types of Alzheimer's disease mutations of amyloid precursor protein. J Biol Chem 2000; 275: 34541-34551.
29. Hatanpaa K, Chandrasekaran K, Brady DR, Rapoport SI. No association between Alzheimer plaques and decreased levels of cytochrome oxidase subunit mRNA, a marker of neuronal energy metabolism. Mol Brain Res 1998; 59: 13-21.
30. Jagannatha Rao KS, Shanmugavelu P, Shankar SK, Rukmini Devi RP, Rao RV, Sanjay P. Trace elements in the cerebrospinal fluid of Alzheimer's disease. Alz Rep 1999; 2: 333-338.
31. Janus C, Westaway D. Transgenic mouse models of Alzheimer's disease. Physiol Behav 2001; 73: 873-886.
32. Jeong SJ, Kim K, Suh YH. Age-related changes in the expression of Alzheimer's beta APP in the brain of senescence accelerated mouse (SAM)-P/10. NeuroReport 1997; 8: 1733-173.
33. Kamboh MI. Molecular genetics of late-onset Alzheimer's disease. Ann Hum Genet 2004; 68: 381-404.
34. Karniely S, Pines O. Single translation-dual destination: mechanisms of dual protein targeting in eukaryotes. EMBO Rep 2005; 6: 420-425.
35. Keil U, Bonert A, Marques CA, Scherping I, Weyermann J, Strosznajder JB, Muller-Spahn F, Haass C, Czech C, Pradier L, Muller WE, Eckert A. Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis. J Biol Chem 2004; 279: 50310-50320.
36. Keil U, Hauptmann S, Bonert A, Scherping I, Eckert A, Muller WE. Mitochondrial dysfunction induced by disease relevant Aβ PP and tau protein mutations. J Alz Dis 2006; 9: 139-146.
37. Leissring MA, Farris W, Wu X, Christodoulou DC, Haigis MC, Guarente L, Selkoe DJ. Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria. Biochem J 2004; 383: 439-446.
38. Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006; 443: 787-795.
39. Loeffler DA, LeWitt PA, Juneau PL, Sima AA, Nguyen HU, DeMaggio AJ, Brickman CM, Brewer GJ, Dick RD, Troyer MD, Kanaley L. Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders. Brain Res 1996; 738: 265-274.
40. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR. Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 1998; 158: 47-52.
41. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, Caspersen C, Chen X, Pollak S, Chaney M, Trinchese F, Liu S, Gunn-Moore F, Lue LF, Walker DG, Kuppusamy P, Zewier ZL, Arancio O, Stern D, Yan SS, Wu H. ABAD directly links Aβ to mitochondrial toxicity in Alzheimer's disease. Science 2004; 304: 448-452.
42. Mancuso M, Siciliano G, Filosto M, Murri L. Mitochondrial dysfunction and Alzheimer's disease: new developments. J Alz Dis 2006; 9: 111-117.
43. Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH. Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 2006; 15: 1437-1449.
44. Manfredi G, Beal MF. The role of mitochondria in the pathogenesis of neurodegenerative diseases. Brain Pathol 2000; 10: 462-472.
45. Mattson MP. Central role of oxyradicals in the mechanism of amyloid β-peptide toxicity. Alz Dis Rev 1997; 2: 1-14.
46. Maurer I, Zierz S, Moller HJ. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging 2000; 21: 455-462.
47. McDermott JR, Smith AI, Iqbal K, Wisniewski HM. Brain aluminum in aging and Alzheimer disease. Neurology 1979; 29: 809-814.
48. Mohs RC. The Alzheimer's Disease Assessment Scale. Int Psychogeriatr 1996; 8: 195-203.
49. Nazarali AJ, Reynolds GP. Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study. Cell Mol Neurobiol 1992; 12: 581-587.
50. Nunan J, Small DH. Regulation of APP cleavage by α-, β- and γ-secretases. FEBS Lett 2000; 483: 6-10.
51. Offen D, Elkon H, Melamed E. Apoptosis as a general cell death pathway in neurodegenerative diseases. J Neural Transm 2000; 58: 153-166.
52. Park HJ, Kim SS, Seong YM, Kim KH, Goo HG, Yoon EJ, Min DS, Kang S, Rhim H. Amyloid precursor protein is a direct cleavage target of HtrA2 serine protease. J Biol Chem 2006; 281: 34277-34287.
53. Parker WD, Mahr NJ, Filley CM, Parks JK, Hughes D, Young DA, Cullum CM. Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology 1994; 44: 1086-1090.
54. Parker WD Jr. Cytochrome oxidase deficiency in Alzheimer's disease. Ann NY Acad Sci 1991; 640: 59-64.
55. Prabhu SK, Anandatheerthavarada HK, Raza H, Srinivasan S, Spear JF, Avadhani NG. Protein kinase A-mediated phosphorylation modulates cytochrome c oxidase function and augments hypoxia and myocardial ischemia-related injury. J Biol Chem 2006; 281: 2061-2070.
56. Price DL, Sisodia SS. Mutant genes in familial Alzheimer's disease and transgenic models. Annu Rev Neurosci 1998; 21: 479-505.
57. Reddy PH. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease. J Neurochem 2006; 96: 1-13.
58. Reddy PH, Beal MF. Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Res Brain Res Rev 2005; 49: 618-632.
59. Rehling P, Wiedemann N, Pfanner N, Truscott KN. The mitochondrial import machinery for preproteins. Crit Rev Biochem Mol Biol 2001; 36: 291-336.
60. Reinikainen KJ, Soininen H, Riekkinen PJ. Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy. J Neurosci Res 1990; 27: 576-586.
61. Robin MA, Anandatheerthavarada HK, Biswas G, Naresh Babu VS, Gordon DM, Pain D, Avadhani NG. Bimodal targeting of microsomal CYP2E1 to mitochondria through activation of an N-terminal chimeric signal by cAMP mediated phosphorylation. J Biol Chem 2002; 277: 40583-40593.
62. Ronnett GV, Hester LD, Nye JF, Conners K, Snyder SH. Human cortical neuronal cell line: establishment from a patient with unilateral megalencephaly. Science 1990; 248: 603-605.
63. Selkoe DJ. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 1999; 399: 23-31.
64. Shepherd CE, Bowes S, Parkinson D, Cambray-Deakin M, Pearson RC. Expression of amyloid precursor protein in human astrocytes in vitro: isoform-specific increases following heat shock. Neuroscience 2000; 99: 317-325.
65. Sims NR. Energy metabolism, oxidative stress and neuronal degeneration in Alzheimer's disease. Neurodegeneration 1996; 5: 435-440.
66. Stephenson DT, Rash K, Clemens JA. Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat. Brain Res 1992; 593: 128-135
67. Tabira T, Chui DH, Kuroda S. Significance of intracellular Aβ42 accumulation in Alzheimer's disease. Front Biosci 2002; 7: 44-49.
68. Taylor SW, Fahy E, Zhang B, Glenn GM, Warnock DE, Wiley S, Murphy AN, Gaucher SP, Capaldi RA, Gibson BW, Ghosh SS. Characterization of the human heart mitochondrial proteome. Nat Biotechnol 2003; 21: 281-286.
69. Thinakaran GJ. The role of presenilins in Alzheimer's disease. Clin Invest 1999; 104: 1321-1327.
70. Truscott KN, Pfanner N, Voos W. Transport of proteins into mitochondria. Rev Physiol Biochem Pharmacol 2001; 143: 81-136.
71. Yamaguchi H, Yamazaki T, Ishiguro K, Shoji M, Nakazato Y, Hirai S. Ultrastructural localization of Alzheimer amyloid beta/A4 protein precursor in the cytoplasm of neurons and senile plaque-associated astrocytes. Acta Neuropathol 1992; 85: 15-22.
72. Zatta P, Lucchini R, van Rensburg SJ, Taylor A. The role of metals in neurodegenerative processes: aluminum, manganese, and zinc. Brain Res Bull 2003; 62: 15-28.
73. Zubenko GS. Neurobiology of major depression in Alzheimer's disease. Int Psychogeriatrics 2000; 12: 217-230.